IL1B and breast cancer: Co-culturing embelin-treated breast cancer cells with hUCMSCs or with IL-1β-stimulated hUCMSCs led to more apoptotic cells than co-culturing untreated breast cancer cells with hUCMSCs or with IL-1β-stimulated hUCMSCs in all three cell lines (Fig. 5b,d,f).